267 related articles for article (PubMed ID: 29683475)
1. Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults.
van den Blink QU; Garcez K; Henson CC; Davidson SE; Higham CE
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010604. PubMed ID: 29683475
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
[TBL] [Abstract][Full Text] [Related]
3. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
4. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy.
Henson CC; Burden S; Davidson SE; Lal S
Cochrane Database Syst Rev; 2013 Nov; (11):CD009896. PubMed ID: 24282062
[TBL] [Abstract][Full Text] [Related]
5. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Bell JM; Shields MD; Watters J; Hamilton A; Beringer T; Elliott M; Quinlivan R; Tirupathi S; Blackwood B
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010899. PubMed ID: 28117876
[TBL] [Abstract][Full Text] [Related]
6. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
7. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.
Lawrie TA; Green JT; Beresford M; Wedlake L; Burden S; Davidson SE; Lal S; Henson CC; Andreyev HJN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012529. PubMed ID: 29360138
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in multiple myeloma: an updated network meta-analysis.
Mhaskar R; Kumar A; Miladinovic B; Djulbegovic B
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003188. PubMed ID: 29253322
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates and other bone agents for breast cancer.
O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
11. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Chung C; Bryant A; Brown PD
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate use in children with cerebral palsy.
Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A; Mak JC; O'Connell D
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for advanced prostate cancer.
Macherey S; Monsef I; Jahn F; Jordan K; Yuen KK; Heidenreich A; Skoetz N
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006250. PubMed ID: 29278410
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for Paget's disease of bone in adults.
Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
19. Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer.
Denham JW; Nowitz M; Joseph D; Duchesne G; Spry NA; Lamb DS; Matthews J; Turner S; Atkinson C; Tai KH; Gogna NK; Kenny L; Diamond T; Smart R; Rowan D; Moscato P; Vimieiro R; Woodfield R; Lynch K; Delahunt B; Murray J; D'Este C; McElduff P; Steigler A; Kautto A; Ball J
BJU Int; 2014 Sep; 114(3):344-53. PubMed ID: 24512527
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
